Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)
OTCMKTS · Delayed Price · Currency is USD
1.090
0.00 (0.00%)
At close: May 12, 2025

Genomma Lab Internacional Company Description

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally.

It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others.

Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Genomma Lab Internacional, S.A.B. de C.V.
Genomma Lab Internacional logo
Country Mexico
Founded 1996
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,633
CEO Juan Marco Sparvieri

Contact Details

Address:
Avenida Antonio Dovalí Jaime No. 70
Mexico City, 01210
Mexico
Phone 52 55 5081 0000
Website genommalab.com

Stock Details

Ticker Symbol GNMLF
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency MXN
ISIN Number MX01LA010006
SIC Code 2834

Key Executives

Name Position
Juan Marco Sparvieri Chief Executive Officer
Lic. Rodrigo Alonso Herrera Aspra Founder and Chairman of the Board
Engineer Antonio Zamora Galland Executive Vice President of Finance and Administration and Chief Financial Officer
Christianne Ibáñez Garcia Head of Investor Relations
Alejandro Bastón Patiño Executive Vice President of Institutional Relations, Media, Human Resources and Sustainability
Efraan Tapia Cardova Secretary
Daniel Suarez Neria Investor Relations Officer